Noda Akiko, Hayano Junichiro, Ito Nami, Miyata Seiko, Yasuma Fumihiko, Yasuda Yoshinari
Department of Biomedical Sciences, Chubu University Graduate School of Life and Health Sciences, Kasugai, Japan.
Innovative Research Center for Preventive Medical Engineering, Nagoya University, Nagoya, Japan.
J Res Med Sci. 2019 Sep 30;24:84. doi: 10.4103/jrms.JRMS_62_18. eCollection 2019.
Although positive airway pressure (PAP) therapy is effective for treating obstructive sleep apnea (OSA), some patients with severe OSA are intolerable to this treatment, which may lead to an increase in the mortality and morbidity of cardiovascular diseases. We investigated the relationship between heart rate variability (HRV) and sleep parameters during natural sleep and treatment of patients with OSA.
This was the cross-sectional observation study. Patients were 17 males with severe OSA who were unable to accept continuous PAP. Standard polysomnography was performed for two consecutive nights, i.e., during natural sleep and following night with bilevel PAP (BiPAP) treatment. Time-dependent responses of the amplitudes of low frequency (LF), very low frequency (VLF), and high frequency components of HRV were assessed with the technique of complex demodulation.
Apnea-hypopnea index, oxygen desaturation time, and percentage of stage 1 sleep were significantly reduced, whereas the percentages of rapid eye movement and stages 3 + 4 sleep were increased, by BiPAP treatment. Therapy also reduced the amplitudes of VLF and LF components of HRV. Difference in amplitudes of VLF during natural sleep and treatment with BiPAP was significantly correlated with difference in percentages of stage 1 and stages 3 + 4 sleep.
Therapy-induced amelioration of OSA and sleep quality was accompanied by decrease in the amplitudes of VLF components of HRV. The VLF component may thus reflect physiological changes in both autonomic activity and sleep structure and serve as an objective marker for therapeutic efficacy in patients with severe OSA.
尽管气道正压通气(PAP)治疗对阻塞性睡眠呼吸暂停(OSA)有效,但一些重度OSA患者无法耐受这种治疗,这可能导致心血管疾病的死亡率和发病率增加。我们研究了OSA患者自然睡眠及治疗期间心率变异性(HRV)与睡眠参数之间的关系。
这是一项横断面观察研究。患者为17名无法接受持续气道正压通气的重度OSA男性患者。连续两晚进行标准多导睡眠监测,即自然睡眠期间及接受双水平气道正压通气(BiPAP)治疗后的夜晚。采用复解调技术评估HRV低频(LF)、极低频(VLF)和高频成分振幅的时间依赖性反应。
BiPAP治疗后,呼吸暂停低通气指数、氧饱和度下降时间及1期睡眠百分比显著降低,而快速眼动睡眠及3+4期睡眠百分比增加。治疗还降低了HRV的VLF和LF成分振幅。自然睡眠期间与BiPAP治疗期间VLF振幅的差异与1期和3+4期睡眠百分比的差异显著相关。
治疗引起的OSA改善和睡眠质量提高伴随着HRV的VLF成分振幅降低。因此,VLF成分可能反映自主神经活动和睡眠结构的生理变化,并可作为重度OSA患者治疗效果的客观指标。